Chronic hepatitis B and C in HIV-infected patients;Chronische hepatitis B und C bei HIV-infizierten patienten

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 24, 1998, Pages 753-760

  Opravil, M ^a   Hunziker, R ^a,b   Luthy R ^a,c   Grob, P J ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

^c Zürcher Lighthouse   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; COMORBIDITY; FEMALE; HEPATITIS B; HEPATITIS C; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETROSPECTIVE STUDY; SWITZERLAND;

EID: 0032511008     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024064     Document Type: Article

References (32)

1. Bodsworth, N.J., D. A. Cooper, B. Donovan: The influence of human immunodeficiency virus type 1 infection on the development of hepatitis B virus carrier state. J. infect. Dis. 163 (1991), 1138-1140.
2. Bodsworth, N.J., P. Cunningham,J. Kaldor, B. Donovan: Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behavior. Genitourin. Med. 72 (1996), 118-122.
3. Campbell, M. J., M. J. Gardner: Calculating confidence intervals for some nonparametric analyses. In Gardner, M. J., D. G. Altman (Eds.): Statistics with confidence (British Medical Journal: London 1989), 71-79.
4. Cribier, B., D. Rey, C. Schmitt, J. M. Lang, A. Kirn, F. Stoll-Keller: High hepatitis viremia and impaired antibody response in patients coinfected with HIV. AIDS 9 (1995), 1131-1136.
5. Dalekos, G. N., M. N. Manoussakis, E. Zervou, E. V. Tsianos, H. M. Moutsopoulos: Immunologic and viral markers in the circulation of anti-HIV negative heroin addicts. Europ. J. clin. Invest. 23 (1993), 219-225.
6. Esteban, J. I., J. C. Lopez Talavera, J. Genesca, P. Madoz, L Viladomiu, E. Muniz, C. Martin-Vega, M. Rosell, H. Allende, X. Vidai, A. Gonzalez, J. M. Hernandez, R. Esteban, J. Guardia: High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann. intern. Med. 115 (1991), 443-449.
7. Gitnick, G.: Hepatitis infection in immunocompromised patients. Gastroenterol. Clin. Nth. Amer. 23 (1994), 515-521.
8. Gordon, S. C., A. H. Patel, G. W. Kulesza, R. E. Barnes, A. L. Silverman: Lack of evidence for the heterosexual transmission of hepatitis C. Amer. J. Gastroenterol. 87 (1992), 1849-1851.
9. Gross, A., H. I. Joller-Jemelka, A. N. Wicki, P. J. Grob: Der Hepatitis-serologische Befund »Anti-HBc allein«, zirkulierende virale DNA und Befund-Interpretation. Schweiz, med. Wschr. 123 (1993), 1193-1202.
10. Hadler, S. C., F. N. Judson, P. M. O'Malley, N. L Altman, K. Penley, S. Buchbinder, C. A. Schable, P. J. Coleman, D.N. Ostrow, D. P. Francis: Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J. infect. Dis. 163 (1991), 454-459.
11. Hofer, M., H. I. Joller-Jemelka, P.J. Grob, R. Lüthy, M. Opravil and the Swiss HIV Cohort Study: Frequent chronic hepatitis B virus infection in HIV-infected patients positive for »antibody to hepatitis B core antigen only«. Europ. J. Clin. Microbiol. Infec. Dis. 17 (1998), 6-13.
12. Hoofnagle, J. H., G. M. Dusheiko, D. F. Schafer, E. A. Jones, K. C. Micetich, R. C. Young, J. Costa: Reactivation of chronic hepatitis B virus infectionby cancer chemotherapy. Ann. intern. Md. 96 (1982), 447-449.
13. Hoofnagle, J. H., I. B. Seeff, Z. Buskell-Bales, H. J. Zimmerman: Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. New Engl. J. Med. 298 (1978), 1379-1383.
14. Horvarth, J., S. P. Raffanti: Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses. Clin. infect. Dis. 18 (1994), 339-347.
15. Joller-Jemelka, H. I., A. N. Wicki, P. J. Grob: Detection of Hbs antigen in »anti-HBc alone« positive sera. J. Hepatol. 21 (1994), 269-272.
16. Kashala, O., L Mubikayi, K. Kayembe, P. Mukeba, M. Essex: Hepatitis B virus activation among Central Africans infected with human immunodeficiency virus (HIV) type 1: Pre-s2 antigen is predominantly expressed in HIV Infection. J. infect. Dis. 169 (1994), 628-632.
17. Larsen, J., G. Hetland, K. Skaug: Posttransfusion hepatitis B. transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion 30 (1990), 431-432.
18. Ledergerber, B., J. von Overbeck, M. Egger, R. Lüthy und Mitarbeiter der »Swiss HIV-Cohort Study« (SHCS): The Swiss HIV Cohort Study: Rationale, organization and selected baseline characteristics. Soz.- und Präventivmed. 39 (1994), 387-394.
19. Luo, K.X., Z.S. Liang, S.C. Yang, R. Zhou, Q.H. Meng, Y.W. Zhu: Etiological investigation of acute post-transfusion non-A, non-B hepatitis in China. J. med. Virol. 39 (1993), 219-223.
20. Ndimbie, O. K., L. A. Kingsley, S. Nedjar, C. R. Rinaldo: Hepatitis C virus infection in a male homosexual cohort: risk factor analysis. Genitourin. Med. 72 (1996), 213-216.
21. Niederau, C., T. Heintges, M. Wenning, A. Erhard, W. Retry, F. Hensel, C. M. Niederau, D. Häussinger: Ergebnisforschung in der Therapie der chronischen Hepatitis C. Internist 37 (1996), 1225-1236.
22. Ockenga, J., H. L. Tillmann, C. Trautwein, M. Stoll, M. P. Manns, R. E. Schmidt: Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J. Hepatol. 27 (1997), 18-24.
23. Osmond, D. H., E. Charlebois, H. W. Sheppard, K. Page, W. Winkelstein, A. R. Moss, A. Reingold: Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J. infect. Dis. 167 (1993), 66-71.
24. Poynard, T., P. Bedossa, P. Opolon for the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups: Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 349 (1997), 825-832.
25. Quan, C. M., M. Krajden, G. A. Grigoriew, I. E. Salit: Hepatitis C virus infection in patients infected with the human immunodeficiency virus. Clin. infect. Dis. 17 (1993), 117-119.
26. Quaranta, J. E., S. R. Delaney, S. Alleman, J. P. Cassuto, P. Dellamonica, J. P. Allain: Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (Nice SEROCO cohort). J. med. Virol. 42 (1994), 29-32.
27. Roudot-Thoraval, F., A. Bastie, J. M. Pawlotsky, D. Dhumeaux, and the Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus: Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6664 patients. Hepatology 26 (1997), 485-490.
28. Scheitlin, T., H. I. Joller-Jemelka, P. J. Grob: Hepatitis and HIV-Infektionen bei Benützern und Benützerinnen illegaler Drogen. Schweiz. med. Wschr. 122 (1992), 1432-1445.
29. Sharara, A. I., C. M. Hunt, J. D. Hamilton: Hepatitis C. Ann. intern. Med. 125 (1996), 658-668.
30. Thomas, D. L., R. O. Cannon, C. N. Shapiro, E. W. Hook 3 rd, M. J. Alter, T. C. Quinn: Hepatitis C, hepatitis B, and human immunodeficiency virus infections among nonintravenous drug-using patients attending clinics for sexually transmitted disease. J. infect. Dis. 169 (1994), 990-995.
31. Wright, T. L., J. Y. Lau: Clinical aspects of hepatitis B virus infection. Lancet 342 (1993), 1340-1344.
32. Zala, G., J. Havelka, A. N. Wicki: Hepatitis-C-Virus-Test der zweiten Generation und PCR bei anti-C100-negativen Patienten mit chronischer Non-A-Non-B-Hepatitis. Schweiz, med. Wschr. 122 (1992), 363-368.